Kopin Corp. said fourth-quarter revenue fell 42% from a year earlier as a government shutdown delayed procurement and shipments, even as the company raised $56 million from strategic and institutional ...
Maze Therapeutics has recently released its 10-K report. Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco that develops small-molecule precision ...
McEwen said its Tartan mine project in Flin Flon, Manitoba now carries an estimated 308,900 indicated gold ounces and 302,700 inferred gold ounces, based on a gold price of US$3,000 an ounce. The ...
Braze recently released its 10-K report. Braze, Inc. operates a customer engagement platform used by brands to manage messaging and data across mobile, web, email, and other channels. The company, ...
ADMA Biologics said March 27 that end-user demand for Asceniv has risen steadily over the past two-plus years and is now at a record high, as the company pushed back against a March 24 short report ...
DBV Technologies narrowed its cash burn outlook and ended 2025 with a much larger cash cushion after a year of heavier spending tied to its peanut patch program and launch preparation. The company ...
Merck agreed to buy Terns Pharmaceuticals for $53.00 a share in cash, valuing the clinical-stage oncology company at about $6.7 billion in equity value, or about $5.7 billion net of acquired cash. The ...
UiPath said Chief Technology Officer Raghu Malpani is taking on an expanded role as chief product and technology officer, effective March 25, 2026. Malpani joined UiPath in May 2024 as CTO, meaning he ...
Dycom Industries has appointed Raejeanne Skillern to its board of directors, effective March 24, 2026. Skillern brings more than 30 years of experience across hyperscale cloud, data center ...
Signet Jewelers has recently released its 10-K report, providing a comprehensive overview of its business operations and financial performance. The company operates as a diamond jewelry retailer with ...
Movado Group, Inc. has announced its fiscal year 2026 results, revealing an increase in net sales, operating income, and EPS compared to the previous year. The company's net sales for fiscal 2026 were ...
Caleres, a leading portfolio of consumer-driven footwear brands, has reported its financial results for the fourth quarter and fiscal year 2025, and has provided guidance for the first quarter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results